Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

Analysis of Solvency Ratios

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Solvency Ratios (Summary)

UnitedHealth Group Inc., solvency ratios

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Debt Ratios
Debt to equity
Debt to equity (including operating lease liability)
Debt to capital
Debt to capital (including operating lease liability)
Debt to assets
Debt to assets (including operating lease liability)
Financial leverage
Coverage Ratios
Interest coverage
Fixed charge coverage

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


Solvency ratios indicate a generally increasing risk profile over the analyzed period. While the company maintains a seemingly stable capital structure through 2023, a noticeable shift occurs from 2024 onwards, with several ratios suggesting increased financial leverage and potentially diminished capacity to meet fixed obligations.

Debt Levels
Debt to equity, both with and without the inclusion of operating lease liabilities, exhibits an upward trend beginning in 2021. Increases are moderate through 2023, but accelerate between 2023 and 2024, stabilizing at higher levels through 2025. Debt to capital ratios follow a similar pattern, though the magnitude of change is smaller. Debt to assets also increases, though at a slower pace, peaking in 2024 before a slight decrease in 2025.
Leverage
Financial leverage consistently increases throughout the period, rising from 2.96 in 2021 to 3.29 in 2025. This indicates a greater reliance on debt financing relative to equity, amplifying both potential returns and risks.
Coverage Ratios
A significant downward trend is observed in both interest coverage and fixed charge coverage ratios. Interest coverage declines substantially from 14.44 in 2021 to 4.67 in 2025, suggesting a diminishing ability to cover interest expenses from earnings. Fixed charge coverage mirrors this trend, decreasing from 8.80 to 3.62 over the same period. This decline indicates a weakening capacity to meet all fixed financial obligations, including both interest and other fixed charges.

The consistent increase in debt ratios coupled with the declining coverage ratios suggests a growing reliance on debt and a reduced margin of safety in meeting financial obligations. While the company appears to manage its debt levels through 2023, the changes observed from 2024 to 2025 warrant further investigation.


Debt Ratios


Coverage Ratios


Debt to Equity

UnitedHealth Group Inc., debt to equity calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
 
Shareholders’ equity attributable to UnitedHealth Group
Solvency Ratio
Debt to equity1
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Debt to Equity, Sector
Health Care Equipment & Services
Debt to Equity, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Debt to equity = Total debt ÷ Shareholders’ equity attributable to UnitedHealth Group
= ÷ =

2 Click competitor name to see calculations.


The debt to equity ratio for the analyzed period demonstrates an increasing trend in financial leverage. Total debt and shareholders’ equity both increased over the five-year period, but debt grew at a faster rate, resulting in a higher ratio.

Debt to Equity Ratio - Overall Trend
The debt to equity ratio increased from 0.64 in 2021 to 0.83 in 2024, remaining at 0.83 in 2025. This indicates a growing reliance on debt financing relative to equity financing.

In 2022, the ratio experienced its largest single-year increase, moving from 0.64 to 0.74. While the ratio decreased slightly in 2023 to 0.70, it resumed its upward trajectory in 2024, reaching 0.83 and holding steady in 2025. This suggests that the decrease in 2023 may have been a temporary fluctuation.

Debt Growth
Total debt increased consistently throughout the period, from US$46,003 million in 2021 to US$78,389 million in 2025. The largest absolute increase in debt occurred between 2023 and 2024, with an addition of US$14,367 million.
Equity Growth
Shareholders’ equity attributable to UnitedHealth Group also increased over the period, rising from US$71,760 million in 2021 to US$94,110 million in 2025. However, the rate of equity growth was consistently lower than the rate of debt growth.

The sustained increase in the debt to equity ratio suggests a potential shift in the company’s capital structure towards greater financial risk. While increased leverage can amplify returns, it also increases the potential for financial distress, particularly if earnings decline.


Debt to Equity (including Operating Lease Liability)

UnitedHealth Group Inc., debt to equity (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
Current operating lease liabilities (included in Other current liabilities)
Noncurrent operating lease liabilities (included in Other liabilities)
Total debt (including operating lease liability)
 
Shareholders’ equity attributable to UnitedHealth Group
Solvency Ratio
Debt to equity (including operating lease liability)1
Benchmarks
Debt to Equity (including Operating Lease Liability), Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Debt to Equity (including Operating Lease Liability), Sector
Health Care Equipment & Services
Debt to Equity (including Operating Lease Liability), Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Debt to equity (including operating lease liability) = Total debt (including operating lease liability) ÷ Shareholders’ equity attributable to UnitedHealth Group
= ÷ =

2 Click competitor name to see calculations.


The debt to equity ratio, including operating lease liability, exhibited an increasing trend over the five-year period. Total debt increased consistently, while shareholders’ equity also grew, though at a varying pace. This resulted in fluctuations in the ratio, ultimately stabilizing at a higher level than observed at the beginning of the period.

Debt to Equity Ratio Trend
In 2021, the debt to equity ratio was 0.70. This increased to 0.80 in 2022, representing a 14.3% rise. A slight decrease was noted in 2023, with the ratio falling to 0.76. However, the ratio resumed its upward trajectory, reaching 0.88 in 2024 and remaining stable at 0.88 in 2025.
Total Debt
Total debt, inclusive of operating lease liabilities, demonstrated consistent growth throughout the period. It increased from US$50,276 million in 2021 to US$83,004 million in 2025, representing a 65.3% increase overall. The largest single-year increase occurred between 2023 and 2024, with an increase of US$14,358 million.
Shareholders’ Equity
Shareholders’ equity attributable to UnitedHealth Group also increased over the period, moving from US$71,760 million in 2021 to US$94,110 million in 2025, a 31.1% increase overall. The rate of growth in equity was not consistent year-over-year, with the largest increase occurring between 2022 and 2023 (US$10,984 million).

The stabilization of the debt to equity ratio at 0.88 in the final two years suggests a potential equilibrium point in the company’s capital structure, despite continued absolute increases in debt. The increasing debt levels, coupled with the growth in equity, indicate ongoing investment and financing activities.


Debt to Capital

UnitedHealth Group Inc., debt to capital calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
Shareholders’ equity attributable to UnitedHealth Group
Total capital
Solvency Ratio
Debt to capital1
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Debt to Capital, Sector
Health Care Equipment & Services
Debt to Capital, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =

2 Click competitor name to see calculations.


The debt to capital ratio exhibits an increasing trend over the observed period, though with some fluctuation. Total debt and total capital both increased in absolute terms from 2021 to 2025, but the rate of increase in debt appears to be influencing the ratio.

Debt to Capital Ratio Trend
In 2021, the debt to capital ratio stood at 0.39. This ratio increased to 0.43 in 2022, indicating a greater proportion of debt financing relative to capital. A slight decrease was observed in 2023, with the ratio falling to 0.41. However, the ratio then increased again in 2024, reaching 0.45, and remained stable at 0.45 in 2025.

The consistent increase from 2021 to 2024 suggests a growing reliance on debt financing. While the ratio stabilized in the final year, it remains at a higher level than the initial value, indicating a shift in the company’s capital structure. The fluctuations suggest potential changes in financing strategies or capital investment decisions during the period.

Total Debt
Total debt increased consistently throughout the period, from US$46,003 million in 2021 to US$78,389 million in 2025. The largest absolute increase occurred between 2023 and 2024, with an addition of US$14,367 million.
Total Capital
Total capital also increased consistently, moving from US$117,763 million in 2021 to US$172,499 million in 2025. The rate of increase in total capital was generally slower than the rate of increase in total debt, contributing to the observed trend in the debt to capital ratio.

The observed trend in the debt to capital ratio warrants further investigation into the reasons behind the increased debt levels and the implications for the company’s financial flexibility and risk profile.


Debt to Capital (including Operating Lease Liability)

UnitedHealth Group Inc., debt to capital (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
Current operating lease liabilities (included in Other current liabilities)
Noncurrent operating lease liabilities (included in Other liabilities)
Total debt (including operating lease liability)
Shareholders’ equity attributable to UnitedHealth Group
Total capital (including operating lease liability)
Solvency Ratio
Debt to capital (including operating lease liability)1
Benchmarks
Debt to Capital (including Operating Lease Liability), Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Debt to Capital (including Operating Lease Liability), Sector
Health Care Equipment & Services
Debt to Capital (including Operating Lease Liability), Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Debt to capital (including operating lease liability) = Total debt (including operating lease liability) ÷ Total capital (including operating lease liability)
= ÷ =

2 Click competitor name to see calculations.


The debt to capital ratio, inclusive of operating lease liabilities, exhibits an increasing trend over the observed five-year period. While not consistently increasing year-over-year, the ratio demonstrates a clear upward trajectory when viewed from 2021 to 2025.

Total Debt (including operating lease liability)
Total debt increased steadily from US$50,276 million in 2021 to US$83,004 million in 2025. The largest absolute increase occurred between 2022 and 2023 (US$5,000 million), and again between 2023 and 2024 (US$14,358 million). The increase from 2024 to 2025 was comparatively modest, at US$1,211 million.
Total Capital (including operating lease liability)
Total capital also increased over the period, moving from US$122,036 million in 2021 to US$177,114 million in 2025. Similar to debt, the most substantial increase in capital occurred between 2023 and 2024 (US$18,260 million). Growth in capital was consistent, though not linear, across all years.
Debt to Capital Ratio
The debt to capital ratio began at 0.41 in 2021, rose to 0.45 in 2022, slightly decreased to 0.43 in 2023, and then increased to 0.47 in both 2024 and 2025. This indicates a growing reliance on debt financing relative to capital. The ratio remained stable at 0.47 in the final two years of the period, suggesting a potential stabilization of the company’s capital structure, albeit at a higher leverage level than in 2021.

The observed increases in both debt and capital suggest overall business expansion. However, the rising debt to capital ratio warrants continued monitoring to assess potential financial risk and the company’s ability to meet its obligations.


Debt to Assets

UnitedHealth Group Inc., debt to assets calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
 
Total assets
Solvency Ratio
Debt to assets1
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Debt to Assets, Sector
Health Care Equipment & Services
Debt to Assets, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Debt to assets = Total debt ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


The debt to assets ratio exhibits an increasing trend over the observed period. Initially, the ratio stood at 0.22 in 2021, and gradually rose to 0.26 in 2024 before decreasing slightly to 0.25 in 2025. This indicates a growing reliance on debt financing relative to the company’s asset base, followed by a minor stabilization in the most recent year.

Total Debt
Total debt increased consistently from US$46,003 million in 2021 to US$78,389 million in 2025. The largest absolute increase occurred between 2023 and 2024, with an addition of US$14,367 million. While growth slowed between 2024 and 2025, debt levels remained high.
Total Assets
Total assets also increased throughout the period, moving from US$212,206 million in 2021 to US$309,581 million in 2025. The rate of asset growth generally kept pace with debt increases, but the debt to assets ratio still increased, suggesting that debt was growing at a proportionally higher rate for a period.
Debt to Assets Ratio Trend
The initial increase in the debt to assets ratio from 0.22 to 0.26 suggests a shift towards greater financial leverage. The slight decrease to 0.25 in 2025 may indicate a deliberate effort to moderate leverage or a faster rate of asset growth compared to debt accumulation. However, the ratio remains elevated compared to its 2021 level.

The observed trend warrants continued monitoring to assess the long-term implications of increased debt financing on the company’s financial stability and flexibility.


Debt to Assets (including Operating Lease Liability)

UnitedHealth Group Inc., debt to assets (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Short-term borrowings and current maturities of long-term debt
Long-term debt, less current maturities
Total debt
Current operating lease liabilities (included in Other current liabilities)
Noncurrent operating lease liabilities (included in Other liabilities)
Total debt (including operating lease liability)
 
Total assets
Solvency Ratio
Debt to assets (including operating lease liability)1
Benchmarks
Debt to Assets (including Operating Lease Liability), Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Debt to Assets (including Operating Lease Liability), Sector
Health Care Equipment & Services
Debt to Assets (including Operating Lease Liability), Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Debt to assets (including operating lease liability) = Total debt (including operating lease liability) ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


The debt to assets ratio, including operating lease liability, exhibits a consistent upward trend over the five-year period. Total debt has increased steadily, while total assets have also grown, but at a slower pace resulting in a rising ratio.

Debt to Assets Ratio Trend
The ratio began at 0.24 in 2021 and increased to 0.27 by 2024, remaining stable at 0.27 in 2025. This indicates a growing reliance on debt financing relative to the company’s asset base.

Total debt increased from US$50,276 million in 2021 to US$83,004 million in 2025, representing a 65.3% increase over the period. While substantial, this increase occurred alongside a 45.8% growth in total assets, from US$212,206 million to US$309,581 million. The slower growth rate of assets compared to debt is the primary driver of the increasing debt to assets ratio.

Debt Growth
The largest absolute increase in total debt occurred between 2022 and 2024, with an addition of US$19,340 million. The increase between 2024 and 2025 was comparatively small, at US$1,211 million.
Asset Growth
Asset growth was most pronounced between 2021 and 2023, increasing by US$61,515 million. Growth slowed in subsequent years, with increases of US$24,558 million between 2023 and 2024, and US$11,303 million between 2024 and 2025.

The consistent increase in the debt to assets ratio suggests a potential shift in the company’s capital structure towards greater leverage. Continued monitoring of this ratio is warranted to assess any potential implications for financial risk.


Financial Leverage

UnitedHealth Group Inc., financial leverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Total assets
Shareholders’ equity attributable to UnitedHealth Group
Solvency Ratio
Financial leverage1
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Financial Leverage, Sector
Health Care Equipment & Services
Financial Leverage, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Financial leverage = Total assets ÷ Shareholders’ equity attributable to UnitedHealth Group
= ÷ =

2 Click competitor name to see calculations.


The financial leverage of the organization exhibits a generally increasing trend over the five-year period from 2021 to 2025. Total assets demonstrate consistent growth throughout the period, while shareholders’ equity attributable to UnitedHealth Group also increases, though at a slower pace than asset growth. This disparity contributes to the observed changes in financial leverage.

Financial Leverage
The financial leverage ratio increased from 2.96 in 2021 to 3.16 in 2022, indicating a greater reliance on debt financing relative to equity. A slight decrease was observed in 2023, with the ratio falling to 3.08. However, this was followed by further increases in 2024 and 2025, reaching 3.22 and 3.29 respectively. This suggests a renewed trend towards increased financial leverage in the latter part of the analyzed period.

The growth in total assets consistently outpaces the growth in shareholders’ equity. This suggests the organization is funding its asset expansion through a combination of retained earnings and debt, with debt playing an increasingly significant role in recent years. The continued increase in financial leverage warrants monitoring to assess potential risks associated with higher debt levels, such as increased interest expense and financial vulnerability during economic downturns.

While shareholders’ equity has increased in absolute terms each year, its growth rate has not been sufficient to offset the larger increases in total assets, resulting in the observed upward trend in financial leverage. The ratio’s movement indicates a shift in the organization’s capital structure towards greater debt financing.


Interest Coverage

UnitedHealth Group Inc., interest coverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Net earnings attributable to UnitedHealth Group common shareholders
Add: Net income attributable to noncontrolling interest
Add: Income tax expense
Add: Interest expense
Earnings before interest and tax (EBIT)
Solvency Ratio
Interest coverage1
Benchmarks
Interest Coverage, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Interest Coverage, Sector
Health Care Equipment & Services
Interest Coverage, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Interest coverage = EBIT ÷ Interest expense
= ÷ =

2 Click competitor name to see calculations.


The interest coverage ratio demonstrates a consistent decline over the five-year period. While initially strong, the ability to meet interest obligations from earnings has diminished significantly.

Earnings Before Interest and Tax (EBIT)
EBIT increased from US$23,970 million in 2021 to US$32,358 million in 2023, representing substantial growth. However, EBIT decreased significantly in subsequent years, falling to US$23,977 million in 2024 and further to US$18,699 million in 2025. This reversal in earnings is a key driver of the declining interest coverage.
Interest Expense
Interest expense exhibited a steady increase throughout the period. From US$1,660 million in 2021, it rose to US$2,092 million in 2022, US$3,246 million in 2023, and continued to climb to US$3,906 million in 2024 and US$4,002 million in 2025. The consistent rise in interest expense, coupled with declining EBIT, has exerted downward pressure on the interest coverage ratio.
Interest Coverage Ratio
The interest coverage ratio began at 14.44 in 2021, indicating a robust capacity to cover interest payments. It decreased to 13.59 in 2022 and continued to fall to 9.97 in 2023. The rate of decline accelerated in 2024, with the ratio dropping to 6.14, and further decreased to 4.67 in 2025. A ratio of 4.67 suggests a considerably reduced margin of safety in meeting interest obligations, and warrants further investigation into the underlying causes of the declining profitability and increasing debt servicing costs.

The combined effect of increasing interest expense and decreasing earnings before interest and tax has resulted in a substantial deterioration in the company’s ability to cover its interest obligations. The trend suggests increasing financial risk.


Fixed Charge Coverage

UnitedHealth Group Inc., fixed charge coverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Net earnings attributable to UnitedHealth Group common shareholders
Add: Net income attributable to noncontrolling interest
Add: Income tax expense
Add: Interest expense
Earnings before interest and tax (EBIT)
Add: Operating lease costs
Earnings before fixed charges and tax
 
Interest expense
Operating lease costs
Fixed charges
Solvency Ratio
Fixed charge coverage1
Benchmarks
Fixed Charge Coverage, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Fixed Charge Coverage, Sector
Health Care Equipment & Services
Fixed Charge Coverage, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= ÷ =

2 Click competitor name to see calculations.


The period under review demonstrates a declining trend in fixed charge coverage despite increasing earnings before fixed charges and tax through 2023. While earnings before fixed charges and tax initially increased from 2021 to 2023, they subsequently decreased in 2024 and 2025. Simultaneously, fixed charges consistently increased throughout the entire period.

Earnings Before Fixed Charges and Tax
Earnings before fixed charges and tax rose from US$25,170 million in 2021 to US$33,758 million in 2023, representing a growth of approximately 34.1%. However, a subsequent decline is observed, with earnings falling to US$25,377 million in 2024 and further decreasing to US$20,299 million in 2025. This represents a decrease of approximately 25.1% from the 2023 peak.
Fixed Charges
Fixed charges exhibited a consistent upward trajectory throughout the period. Starting at US$2,860 million in 2021, they increased to US$3,392 million in 2022, US$4,646 million in 2023, US$5,306 million in 2024, and reached US$5,602 million in 2025. This represents an increase of approximately 95.8% from 2021 to 2025.
Fixed Charge Coverage
The fixed charge coverage ratio decreased steadily from 8.80 in 2021 to 3.62 in 2025. While remaining above 7.0 until 2023, the ratio experienced a more pronounced decline in 2024 to 4.78 and continued to fall in 2025. This indicates a weakening ability to meet fixed obligations from available earnings. The decline is attributable to the combination of decreasing earnings before fixed charges and tax and increasing fixed charges.

The increasing fixed charges, coupled with the recent decline in earnings before fixed charges and tax, suggest a potential increase in financial risk. Continued monitoring of these trends is warranted to assess the long-term solvency position.